India pharma giants and global big pharma join forces for NMEs commercialisation in India: GlobalData Read more
Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of Sintilimab injection plus Bevacizumab biosimilar injection Read more